Meridian Bioscience Stock

Meridian Bioscience R&D per Employee

The R&D Spending per Employee of Meridian Bioscience (VIVO) as of Sep 11, 2026 is 36,871.21 USD. In the previous year, R&D Spending per Employee was 36,228.79 USD — a change of 1.77% (higher).

R&D per Employee

36,871.21USD

YoY

1.77%

Last updated:

R&D Spending per Employee of Meridian Bioscience is 2026 36,871.21 USD. R&D Spending per Employee of Meridian Bioscience was 2025 36,228.79 USD. It decreases by 1.77% higher compared to the previous year.

The Meridian Bioscience R&D per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D per Employee
Date
R&D per Employee
Jan 1, 2015
19,090.91 USD
Jan 1, 2016
21,515.15 USD
Jan 1, 2017
24,242.42 USD
Jan 1, 2018
25,151.52 USD
Jan 1, 2019
26,969.70 USD
Jan 1, 2020
35,909.09 USD
Jan 1, 2021
36,228.79 USD
Jan 1, 2022
36,871.21 USD
The Meridian Bioscience R&D per Employee history
YEARR&D per EmployeeYoY
36,871.21USD+1.77%
36,228.79USD+0.89%
35,909.09USD+33.15%
26,969.70USD+7.23%
25,151.52USD+3.75%
24,242.42USD+12.68%
21,515.15USD+12.70%
19,090.91USD0.00%
19,090.91USD
Access this data via the Eulerpool API

Meridian Bioscience Stock analysis

What does Meridian Bioscience do? Meridian Bioscience Inc. is a global company specializing in the development, manufacture, and distribution of test kits for the diagnosis of infectious diseases and other medical conditions. The company was founded in 1976 by William J. Motto and initially focused on the development of enzyme immunoassays (EIA). Over the years, the company has grown and diversified its product offerings, becoming a leading provider of diagnostic test kits for acute and chronic medical conditions, infectious diseases, gastrointestinal infections, and virology. The company's success is attributed to its diverse range of test kits in various medical areas, including immunology, infectious diseases, sexually transmitted diseases, gastroenterology, and virology. Additionally, Meridian Bioscience Inc. stays up-to-date with the latest technological advancements in biotechnology to ensure the fast and effective performance of its tests. The company operates globally, collaborating with universities, research institutions, government agencies, and distributors to ensure the worldwide distribution and marketing of its products. In summary, Meridian Bioscience Inc. is an innovative company specializing in the development, manufacture, and distribution of test kits for the diagnosis of infectious diseases and other medical conditions. Its wide range of products, including immunology products, infectious disease diagnostics, sexually transmitted disease test kits, gastroenterology, virology, and molecular diagnostics, coupled with advanced technologies, provides fast, accurate, and reliable diagnostic support. Meridian Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Meridian Bioscience stock

R&D Spending per Employee of Meridian Bioscience is 36,871.21 USD in 2026.

R&D Spending per Employee of Meridian Bioscience changed from 36,228.79 USD to 36,871.21 USD, representing a 1.77% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of R&D Spending per Employee Meridian Bioscience since 2006 – with annual values, charts, and detailed analysis.

R&D per employee shows the research and development investment allocated per employee. Higher values indicate innovation-focused companies.

R&D Spending per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track R&D Spending per Employee's Meridian Bioscience historically and in real time.

Access this data via the Eulerpool API

Workforce — Meridian Bioscience

All Key Metrics — Meridian Bioscience